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a  b  s  t  r  a  c  t
Flavobacterium  psychrophilum  is  a well-known  pathogen  causing  signiﬁcant  problems  in  aquaculture
worldwide.  In recent  years  an  increasing  number  of  disease  outbreaks  caused  by F. psychrophilum  has  been
reported  on  juvenile  and  post  smolts  of  rainbow  trout  (Oncorhynchus  mykiss)  in Norway.  The  current  study
was  performed  to  assess  the  efﬁcacy  of  two  autogenous  water-in-oil  formulated  vaccines  containing
whole  cell  antigens  of  F.  psychrophilum  to  induce  protective  immunity  against  challenge.  The  vaccines
were  formulated  either  as multivalent  (FLAVO  AVM6)  or divalent  (FLAVO  IPN)  and  administered  by  the
intraperitoneal  route.  Intramuscular  challenge  with  a ﬁeld  strain  of  F.  psychrophilum  was  carried  out
552  day  degrees  post  vaccination,  at a  time  when  the  FLAVO  AVM6  and  FLAVO  IPN vaccinated  groupsainbow trout
ntramuscular challenge
ntibody response
ultivalent vaccine
ivalent vaccine
lceration
had  signiﬁcantly  higher  antibody  responses  compared  to  the  negative  control.  Results  from  the  challenge
study  showed  that  the  multivalent  and  the  divalent  vaccines  had  capacity  to  induce  signiﬁcant  protection,
with  RPS60 >  87% and  RPSend >  77.5%  for both  vaccines.  The  high  level  of  protection  seen  in the  vaccinated
groups  was  also  reﬂected  in  the  reduced  ulceration  rates  observed  at the  injection  site.  Combining  our
results  demonstrate  that  vaccination  with  FLAVO  AVM6  and  FLAVO  IPN  induces  responses  capable  of
protecting  rainbow  trout  against  infections  with  F.  psychrophilum.
© 2013 Elsevier Ltd. Open access under CC BY-NC-ND license.. Introduction
Flavobacterium psychrophilum is a Gram negative bacterium
ausing rainbow trout fry syndrome (RTFS) and bacterial cold water
isease (BCWD) in salmonids [1]. Clinical severity may  vary con-
iderably and depend mainly on strain virulence and ﬁsh size, with
ortality generally being highest in fry (<5 g) and throughout the
resh water stages [2,3]. During outbreaks, ulcerations in the skin
nd muscle are often observed along with systemic spread of the
acteria to the spleen, head kidney and heart [4–6].
Antimicrobial therapy is still the most used practice to treat
isease outbreaks caused by F. psychrophilum.  As therapy resis-
ance is an increasing problem, development of efﬁcient vaccines
eems to be the only foreseeable prophylactic measure to reduce
he establishment, progression and spread of the disease. Immer-
ion vaccines have so far fell short in giving sufﬁcient and durable
rotecting against RTFS in salmonid fry [7].  Efﬁcient injection vac-
ines might thus be crucial to protect high value species such as
∗ Corresponding author. Tel.: +47 95 96 09 91; fax: +47 23 29 85 01.
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Open access under CC BY-NC-ND license.salmonids against F. psychrophilum at later stages in the production
cycle. Formulations containing immunodominant/immunogenic
sub-unit antigens or heat- and formalin inactivated whole bac-
terins, as well as DNA based vaccine delivery systems have been
reported on mono- or polyvalent injection vaccines against F. psy-
chrophilum. A study using heat shock proteins (Hsp) 60 and 70
from F. psychrophilum either as sub-unit or DNA  vaccines concluded
that these antigens were poor inducers of antibody responses and
protective immunity [8],  while using a 18 kDa outer membrane-
associated OmpH-like glycoprotein has been suggested to have the
capability to induce high antibody titers and signiﬁcant protective
immunity in rainbow trout [9–11]. However, comparing sub-unit
(P25-33, a 25–33 kDa protein fraction) and inactivated bacterins
(either sonicated or whole cell) administered without an oil-
adjuvant demonstrated that the latter resulted in the highest level
of protection and superior vaccine induced antibody responses
[12]. Furthermore, cross protection between the two  serotypes (Fd
isolate F6A/00 and Th isolate P13-4/96) has been demonstrated
after intraperitoneal administration of oil-adjuvanted vaccines fol-
lowed by intramuscular challenge, suggesting that serologically
different F. psychrophilum share protective antigen(s). For multi-
valent vaccines against F. psychrophilum it has been proposed that
accine
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ertain vaccine compositions, in terms of what bacterial antigens
re included, might have inhibitory effect on the speciﬁc responses
o the vaccine antigens [13].
In recent years an increasing number of disease outbreaks
aused by F. psychrophilum have been recorded in rainbow trout
nd Atlantic salmon (Salmo salar L) both at hatcheries and farming
ites in Norway [4;5], making the need for development of efﬁ-
acious vaccines more evident. Previously we have established a
hallenge model using a highly virulent Norwegian ﬁeld strain of
. psychrophilum for challenge of rainbow trout by the intramuscu-
ar route (paper in review). Using an optimized challenge protocol
ith discriminatory capacity between protected and un-protected
sh, we here report efﬁcacy data after vaccination of rainbow trout
ith either a divalent (FLAVO IPN) or a multivalent (FLAVO AVM6)
njection vaccine followed by challenge with the highly virulent
eld strain of F. psychrophilum.
. Materials and methods
.1. Research animals and rearing conditions
Commercially bred un-vaccinated rainbow trout with an aver-
ge body weight of 33.1 g (±SD 5.3 g) were obtained from Lerøy
est, Dep. Sauvågen. The ﬁsh were acclimatized for a minimum
f 1 week prior to vaccination or challenge and fed ad libitum
ith a commercial feed during all experiments. One day prior
o vaccination or challenge ﬁsh were taken off feed. All stud-
es were performed at the facilities of Bergen High Technology
enter (HIB) using fresh water at a temperature of 12 ◦C, oxygen
aturation above 70% in the outlet at all times and a daily pho-
operiod of 12 h. The ﬁsh had no previous disease history as a
onsequence of Flavobacterium encounter. To distinguish between
he experimental groups, ﬁsh were assigned group identity either
y careful cutting of the adipose ﬁn or shortening of the max-
llae. All experiments were in accordance with the Guideline on
he design of studies to evaluate the safety and efﬁcacy of ﬁsh
accines (EMA/CVMP/IWP/314550/2010), the European Pharma-
opeia 7.0 (5.2.7. Evaluation of efﬁcacy of veterinary vaccines and
mmunosera) and approved by The Norwegian Animal Research
uthority (NARA).
.2. Cultivation of bacterial isolates
F. psychrophilum isolates AL20211 (challenge isolate) and
L20055 (vaccine isolate) were isolated from rainbow trout during
eld outbreaks in Norwegian waters in 2011 and 2009, respec-
ively. Prior to the use of AL20211 in challenge trials or as antigens
or detections of speciﬁc antibodies using the enzyme-linked
mmunosorbent assay (ELISA), cultivation was performed on tryp-
one yeast extract salts (TYES) broth and agar at 15 ◦C [14]. All
noculums were aliqouted and stored at −80 ◦C until use. Plate
ount quantiﬁcation of bacteria was performed after thawing.
.3. Vaccination
At vaccination, a total number of 338 rainbow trout were ran-
omly extracted from the holding tank (500 L) and anesthetized
sing tricaine methane sulphonate (Tricaine Pharmaq) at 50 mg/L
uffered with an equal amount of sodium bicarbonate. Vaccina-
ion was performed by intraperitoneal injection of 0.1 ml  FLAVO
VM6 (autogenous multivalent vaccine batch 3430) or 0.05 ml
LAVO IPN (experimental autogenous divalent vaccine), while a
on-injected group was included as a negative control (Table 1).
s previous studies including an adjuvant-only group (vaccine not
ontaining F. psychrophilum antigens) did not demonstrate pro-
ection after challenge (paper in review), an adjuvant-only group 31 (2013) 1994– 1998 1995
was  excluded from the current study. Vaccination was carried
out using a Socorex® automatic syringe with a 0.6 mm × 4 mm
needle (UNIMED). FLAVO AVM6 and FLAVO IPN are two  mineral
oil adjuvanted (water-in-oil emulsions) vaccines containing equal
amounts of formalin inactivated whole F. psychrophilum cells. Fish
were allocated to a new holding tank and kept for 552 day degrees
for induction of immunity after vaccination.
2.4. Pre-challenge of un-vaccinated ﬁsh
The susceptibility of the rainbow trout to intramuscular chal-
lenge with F. psychrophilum was determined by performing a
pre-challenge test on a small number of un-vaccinated ﬁsh.
Fifteen randomly selected ﬁsh were challenged with 0.05 ml
PBS solution containing F. psychrophilum isolate AL20211 at
concentrations equal to 1 ×107 colony forming units (CFU)/ml,
5 ×106 CFU/ml, 1 × 106 CFU/ml, 5 × 105 CFU/ml, 1 × 105 CFU/ml,
5 ×104 CFU/ml, 1 × 104 CFU/ml, 5 × 103 CFU/ml or 1 × 103 CFU/ml.
The pre-challenge test was carried out in a 150 L tank for 32 days.
Fifteen ﬁsh that remained un-challenged were included as controls
for horizontal disease transmission.
2.5. Challenge procedures
Intramuscular challenge was  performed in 4 parallel 150 L tanks
with a minimum of 25 ﬁsh/group/tank (Table 2). Vaccinated groups
and negative controls were challenged with F. psychrophilum iso-
late AL20211 at a concentration of 1 ×105 CFU/ml suspended in
0.05 ml  PBS. Similar to the pre-challenge, injection was performed
using 0.5 ml  BD Micro-FineTM U-100 insulin syringes (BD Medical).
The challenge dose was  placed in the muscle approximately 1 cm
on the dorsal site of the lateral line, slightly posterior to the dor-
sal ﬁn. After challenge, ﬁsh and tanks were tended and monitored
on a daily basis by the test facility and environmental parameters
were recorded every morning. Based on mortality, relative percent-
age survival (RPS) was calculated at the time point corresponding
to 60% mortality in the control group (RPS60) while RPS at end-
point (RPSend) was calculated at the time point when mortality had
ceased in the control group. The challenge study was  terminated at
the time when mortality had ceased in all experimental groups for
a minimum of 3 consecutive days.
2.6. Sampling of blood and registration of ulceration
Blood samples were collected from the caudal vein of 10
ﬁsh/group at the time of challenge using 4 ml vacutainers contain-
ing lithium heparin (Becton Dickinson). Plasma was  separated from
whole blood by centrifugation at 1500 × g at 18 ◦C for 15 min  and
stored at −20 ◦C until analysis.
Deceased ﬁsh were continuously investigated for disintegration
of the surface of the skin at the site of injection. Records were made
in a binary manner (present or not present) with ulcers seen as
major swellings or lesions/skin disintegration registered as posi-
tives. At the end of the experiment all survivors were accounted
for and scored.
2.7. ELISA
ELISA was performed on 96-well polystyrene microtiter plates
(NunclonTM  Surface). Wells were coated with 100 l anti-
gen (F. psychrophilum isolate AL20055). All wells were washed 3
times in PBST (PBS containing 0.05% Tween 20) between every
incubation step (BioTek ELx405). Unspeciﬁc binding was  blocked
with 5% dry milk in PBST for 1 h at room temperature. Plasma
from rainbow trout was  added in two-fold dilutions from 1:25
to 1:102,400 in PBST with 1% dry milk and incubated over night
1996 B.N. Fredriksen et al. / Vaccine 31 (2013) 1994– 1998
Table  1
Summary of experimental groups, vaccine content and allocation of ﬁsh during challenge.
Experimental group Formulation Antigenic contenta Vaccine volume injected (ml) Fish per tank during challenge
Tank 1 Tank 2 Tank 3 Tank 4
Negative control – None Not injected 25 25 25 27
FLAVO IPN W/O  F.psy, IPNV 0.05 25 25 25 27
FLAVO AVM6 W/O  A.sal, L.ang O1, L.ang O2, M.vis, V.sal, F.psy 0.1 25 26 26 27
a
 Listonella anguillarum O2, M.vis – Moritella viscosa, V.sal – Vibrio salmonicida, F.psy –
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aA.sal – Aeromonas salmonicida, L.ang O1 – Listonella anguillarum O1, L.ang O2 –
lavobacterium psychrophilum, IPNV – infectious pancreatic necrosis virus.
t 4 ◦C. F. psychrophilum speciﬁc antibodies were detected using
C10 mouse-anti-trout monoclonal antibodies [15] (Norwegian
eterinary Institute, Oslo) diluted 1:3800 in PBST/1% dry milk for
 h, followed by incubation with rabbit–anti-mouse alkaline phos-
hatase immunoglobulin (1:500 in PBST/1% dry milk) for 1 h (Dako).
itrophenyl phosphate (NPP) was used as substrate at a concen-
ration of 1.0 mg/ml  and the reaction was stopped after 30 min.
eading of optical density (OD) was carried out using a BioTek
L 800 plate reader at OD405 with the Gen 5 data analysis soft-
are. All results were expressed as the dilution factor at which the
D405-reading was 0.5.
.8. Statistical analysis
Data processing was performed using Microsoft Excel, while
raphPad PRISM 5 was used to generate graphs and analyze for sta-
istical differences. Ulceration rates and antibody responses were
nalyzed using the non-parametric one-way ANOVA test in addi-
ion to two-tailed, unpaired t-tests to compare two  experimental
roups. The two-tailed Fisher’s exact test was used to determine
ifferences in the registered mortality. In all cases a p-value of <0.05
as considered signiﬁcant.
. Results
.1. Pre-challenge of un-vaccinated rainbow trout
Accumulated mortality in the pre-challenge ranged from 77.8%
o 100% (results not shown). In the groups challenged with bacte-
ial concentrations ranging from 1 × 104 CFU/ml to 1 × 107 CFU/ml
ortality was the highest (86.7%–100%) and ﬁrst registered at days
–11, while the lower concentrations (1 × 103 CFU/ml and 5 × 105
FU/ml) showed delayed mortality starting at days 12–14 with
7.8% and 86.7% accumulated mortality, respectively. Mortality
rogression was similar between groups, irrespective of challenge
oncentration..2. Antibody responses against F. psychrophilum
Blood plasmas were collected from 10 rainbow trout per
xperimental group at the time of challenge (552 day degrees
able 2
elative percent survival (RPS) and accumulated mortality in all tanks after intramuscular
ere  estimated by comparing the FLAVO AVM6 and FLAVO IPN vaccinated rainbow trout
Experimental group Challenge tank 
Tank 1 
Negative control Acc.morta 88.5 
FLAVO  IPN RPS60 93.3 
RPSend 82.6 
Acc.mort 15.4 
FLAVO  AVM6 RPS60 93.3 
RPSend 87.0 
Acc.mort 11.5 
Acc.mort – accumulated mortality.Fig. 1. Speciﬁc antibody responses against F. psychrophilum isolate AL20055 prior
to  challenge 552 day degrees post vaccination (n = 10).
post vaccination) and analyzed for speciﬁc antibodies against
F. psychrophilum using ELISA. Results showed that ﬁsh vacci-
nated with FLAVO AVM6 (OD405 = 880 ± 169) and FLAVO IPN
(OD405 = 3240 ± 873) had signiﬁcantly higher antibody responses
compared to the non-injected control group (OD405 = 30 ± 5)
(Fig. 1). The two vaccinated groups had antibody levels that were
not statistically different.
3.3. Challenge of vaccinated rainbow trout
Survival rates from the challenge study were presented as a
Kaplan–Meyer plot, as shown in Fig. 2. Acute mortality started in
the non-injected control group at day 9, while it was delayed by
3 days in the vaccinated groups starting at day 12. This delayed
onset of mortality was reﬂected in the high RPS60 values in the
vaccinated groups (Table 2). Accumulated mortality in the control
group reached the same levels (>90%) in the main challenge and
the pre-challenge and both showed an acute progression. At the
time of challenge termination, accumulated mortality in the FLAVO
AVM6 and FLAVO IPN vaccinated groups were extremely statis-
tically signiﬁcant (p < 0.0001) compared to the negative control
 challenge of experimental groups with F. psychrophilum strain AL20211. RPS values
 to the negative control.
Average
Tank 2 Tank 3 Tank 4
100.0 92.3 96.2 94.3
93.3 86.7 80.0 88.3
88.5 75.0 72.0 79.5
11.5 23.1 26.9 19.2
86.7 86.7 93.3 90.0
69.0 66.4 87.5 77.5
31.0 31.0 12.0 21.4
B.N. Fredriksen et al. / Vaccine
Fig. 2. Survival rates after intramuscular challenge of vaccinated (FLAVO AVM6
or  FLAVO IPN) and un-vaccinated (negative control) rainbow trout with F. psy-
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shrophilum isolate AL20211. Each graph represents the average results for 4 parallel
anks holding about 25 ﬁsh/challenge group (p < 0.0001).
Fig. 1 and Table 2). Although tank differences were observed, the
verage RPS60, RPSend and accumulated mortality were similar
etween the FLAVO AVM6 and FLAVO IPN vaccinated groups.
.4. Registration of ulceration
Generally, ﬁsh that died after intramuscular challenge with F.
sychrophilum had visible focal ulcerations limited to the injection
ite. Ulcerations were seen as necrotic skin lesions and in some
ases the muscle erosion had resulted in exposure of the spinal cord.
ost survivors were found to have the surface of the skin intact,
owever minor swellings were observed in some cases. In the con-
rol group ulcerations were found on 72.5% of the ﬁsh (Fig. 3).
lceration rates were signiﬁcantly lower (p < 0.0005) in the FLAVO
PN and FLAVO AVM6 vaccinated groups from where 12.7% and
5.7% of the ﬁsh were found to have ulcerations at the injection
ite, respectively.
. Discussion
The present study demonstrates that the multivalent FLAVO
VM6 and the divalent FLAVO IPN vaccines containing inactivated
hole cell antigens of F. psychrophilum were able to protectainbow trout against bacterial cold water disease. Intramuscular
hallenge was performed approximately 8 weeks post vaccination
t which the ﬁsh had reached a size ranging from 60 to 80 g. This
oute of challenge was chosen as other infection models where
ig. 3. Ulceration rates at the site of challenge injection. Each line displays the
verage of 4 parallel tanks with 25 ﬁsh/experimental group/tank. The column bar
raph shows the accumulated results including standard deviation and statistical
igniﬁcance. 31 (2013) 1994– 1998 1997
F. psychrophilum infection is established by more natural means
(e.g. immersion or cohabitation) are difﬁcult to reproduce with
adequately high mortality [16], partly because of increased resis-
tance to experimental infections at this ﬁsh size. The pre-challenge
was  performed on un-vaccinated rainbow trout using a ﬁeld strain
(AL 20211) of F. psychrophilum for which previous studies have
demonstrated high virulence (paper in review). End point mortal-
ity on un-vaccinated ﬁsh in the pre-challenge and main challenge
was  consistently above 88.5% demonstrating the reproducibility
of our challenge model. Furthermore, the negative (unchallenged)
control group cohabited with the challenged ﬁsh did not show
any mortality during the pre-challenge. This implied that the
challenge pressure contributed by horizontal transmission of F.
psychrophilum could be considered insigniﬁcant and that the main
cause of mortality was  the intramuscularly injected challenge dose.
Oil-adjuvanted vaccines are known to be strong inducers of
inﬂammatory and humoral responses in the form of antigen spe-
ciﬁc antibodies [17,18]. For inactivated F. psychrophilum bacterins,
protection has been demonstrated both for oil-adjuvanted [19,20]
and non-formulated vaccines [12]. Moreover, speciﬁc antibodies
have been found 7 months post vaccination in ﬁeld trials [19]. In
our study, signiﬁcantly higher antibody titers were measured 552
day degrees post vaccination in the FLAVO AVM6 and FLAVO IPN
vaccinated groups compared to the un-vaccinated control group.
Even though ﬁsh in the FLAVO IPN vaccinated group showed about
3.7 times higher average antibody titer compared to the FLAVO
AVM6 vaccinated group, the antibody levels could not be related to
the survival rates as both vaccines were able to induce the same
level of protection against the challenge. This suggests that the
level of antibodies induced by both vaccines had reached a certain
threshold needed for protection to be conferred against this route
of challenge.
Skin and muscle ulcers are typical clinical sign of F. psy-
chrophilum infections [21]. Not only may  ulcers and necrotic tissues
result in reduced animal welfare, but also contribute to signiﬁ-
cant down classiﬁcation of the ﬁlet. Proteolytic activity (gelatin,
casein and cartilage collagen degradation) related to muscle necro-
sis could be a possible virulence factor for F. psychrophilum [22]
as tissue dissolution frees nutrients that may  further support and
amplify bacterial growth. This may  also privilege other pathogens
to establish infections as an important portal of entry has been
breached. In the current study ulceration during disease progres-
sion was related to the efﬁcacy of the vaccines as observed in the
challenge tests and was almost equally rated in the FLAVO AVM6
(15.7%) and FLAVO IPN (12.7%) vaccinated groups while ulcers were
found in 72.5% of the un-vaccinated control group post challenge.
Irrespective of experimental group, ulcers were registered in 60-
70% of the ﬁsh that died due to challenge. Taken together with the
ﬁnding that 94.3% of the ﬁsh in the negative control group died as
a result of the intramuscular challenge this underlines the heavy
infection pressure represented by this route of challenge. In addi-
tion, the pre-challenge revealed the highly opportunistic nature of
F. psychrophilum in muscle tissue as challenge concentrations as
low as 1 × 103 CFU/ml, corresponding to 50 bacteria being injected
per ﬁsh, could bring about 77.8% accumulated mortality. The fact
that about 20% of the ﬁsh in the vaccinated groups died after chal-
lenge could thus have been a result of the heavy infection pressure
shifting the host-pathogen balance too far in favor of the pathogen,
rather than the ability of the vaccines to induce protection.
The present study is to our knowledge one of the ﬁrst to
demonstrate protective immunity induced by a multi- or divalent
water-in-oil formulated vaccine against F. psychrophilum.  From our
results we  conclude that vaccination with FLAVO AVM6 or FLAVO
IPN leads to production of speciﬁc antibodies that contribute to
protect rainbow trout against ulcerations and mortality caused by
acute BCWD.
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